000 01661 a2200457 4500
005 20250513202929.0
264 0 _c20000310
008 200003s 0 0 eng d
022 _a0006-291X
024 7 _a10.1006/bbrc.2000.2184
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJaffee, B D
245 0 0 _aInhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cFeb 2000
300 _a647-51 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aButadienes
_xpharmacology
650 0 4 _aEdema
_xprevention & control
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aJNK Mitogen-Activated Protein Kinases
650 0 4 _aMAP Kinase Kinase 1
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMitogen-Activated Protein Kinase 3
650 0 4 _aMitogen-Activated Protein Kinase Kinases
_xantagonists & inhibitors
650 0 4 _aMitogen-Activated Protein Kinases
_xmetabolism
650 0 4 _aNitriles
_xpharmacology
650 0 4 _aPhosphorylation
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
700 1 _aManos, E J
700 1 _aCollins, R J
700 1 _aCzerniak, P M
700 1 _aFavata, M F
700 1 _aMagolda, R L
700 1 _aScherle, P A
700 1 _aTrzaskos, J M
773 0 _tBiochemical and biophysical research communications
_gvol. 268
_gno. 2
_gp. 647-51
856 4 0 _uhttps://doi.org/10.1006/bbrc.2000.2184
_zAvailable from publisher's website
999 _c10633575
_d10633575